E-LIB Suche - Ergebnisse für: Arana, Alejandro

1

Lessons learned from a multi‐data source research collabora..:

de Vogel, Stefan ; Seeger, John D. ; Arana, Alejandro...
Pharmacoepidemiology and Drug Safety. 33 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

2

Post-Authorization Safety Studies of Acute Liver Injury and..:

Danysh, Heather E. ; Johannes, Catherine B. ; Beachler, Daniel C....
Drug Safety. 46 (2022) 2 - p. 175-193 , 2022

Link: https://doi.org/10.1007/..

3

Post-Authorization Safety Study of Hospitalization for Acut..:

Johannes, Catherine B. ; Beachler, Daniel C. ; Layton, J. Bradley...
Drug Safety. 46 (2022) 2 - p. 157-174 , 2022

Link: https://doi.org/10.1007/..

4

Cardiovascular Risk in Users of Mirabegron Compared with Us..:

Hoffman, Veena ; Hallas, Jesper ; Linder, Marie...
Drug Safety. 44 (2021) 8 - p. 899-915 , 2021

Link: https://doi.org/10.1007/..

5

Long-Term Risk of Skin Cancer and Lymphoma in Users of Topi..:

Arana, Alejandro ; Pottegård, Anton ; Kuiper, Josephina G...
Clinical Epidemiology. 13 (2021) - p. 1141-1153 , 2021

Link: https://doi.org/10.2147/..

6

A study of cancer occurrence in users of mirabegron and ant..:

Phiri, Kelesitse ; Hallas, Jesper ; Linder, Marie...
Current Medical Research and Opinion. 37 (2021) 5 - p. 867-877 , 2021

Link: https://doi.org/10.1080/..

7

Validation of cardiovascular outcomes and risk factors in t..:

Arana, Alejandro ; Margulis, Andrea V ; Varas‐Lorenzo, Cristina...
Pharmacoepidemiology and Drug Safety. 30 (2020) 2 - p. 237-247 , 2020

Link: https://doi.org/10.1002/..

8

Effectiveness of risk minimization measures for the use of ..:

Castellsague, Jordi ; Poblador‐Plou, Beatriz ; Giner‐Soriano, Maria...
Pharmacoepidemiology and Drug Safety. 27 (2018) 9 - p. 953-961 , 2018

Link: https://doi.org/10.1002/..

9

List of Contributors:

, In: Post-Authorization Safety Studies of Medicinal Products,

Ali, Ayad K. ; Arana, Alejandro ; Baxter, Roger... - p. xi-xii , 2018

Link: https://doi.org/10.1016/..

10

Incidence of Common Cancers in Users of Antimuscarinic Medi..:

Hallas, Jesper ; Margulis, Andrea V. ; Pottegård, Anton...
Basic & Clinical Pharmacology & Toxicology. 122 (2018) 6 - p. 612-619 , 2018

Link: https://doi.org/10.1111/..

11

Variation in Cardiovascular Risk Related to Individual Anti..:

Arana, Alejandro ; Margulis, Andrea V. ; McQuay, Lisa J....
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 38 (2018) 6 - p. 628-637 , 2018

Link: https://doi.org/10.1002/..

12

Validation of Cancer Cases Using Primary Care, Cancer Regis..:

Margulis, Andrea V. ; Fortuny, Joan ; Kaye, James A....
Epidemiology. 29 (2018) 2 - p. 308-313 , 2018

Link: https://www.jstor.org/st..

13

Patterns of use of antimuscarinic drugs to treat overactive..:

Margulis, Andrea V. ; Linder, Marie ; Arana, Alejandro...
PLOS ONE. 13 (2018) 9 - p. e0204456 , 2018

Link: https://doi.org/10.1371/..

14

Value of Free-text Comments for Validating Cancer Cases Usi..:

Margulis, Andrea V ; Fortuny, Joan ; Kaye, James A...
Epidemiology. 29 (2018) 5 - p. e41-e42 , 2018

Link: https://www.jstor.org/st..

15

Characterization of new users of cilostazol in the UK, Spai..:

Castellsague, Jordi ; Perez-Gutthann, Susana ; Calingaert, Brian...
Pharmacoepidemiology and Drug Safety. 26 (2017) 6 - p. 615-624 , 2017

Link: https://doi.org/10.1002/..